Table 1

Hemorrhage distribution across the treatment groups

HeadingOverall (n (%))TreatmentOR (95% CI)P value
Intravenous alteplase and EVT (n (%))
(n=292)
EVT-only (n (%))
(n=299)
Any hemorrhage254 (43.0)134 (45.9)120 (40.1)1.27 (0.91 to 1.75)0.16
Symptomatic ICH32 (5.4)20 (6.8)12 (4.0)1.90 (0.90 to 3.99)0.095
Asymptomatic ICH222 (37.6)114 (39.0)108 (36.1)1.20 (0.85 to 1.68)0.30
Hemorrhage type*
HI-112 (2.1)6/287 (2.1)6/297 (2.0)1.13 (0.36 to 3.58)0.83
HI-2127 (21.7)61/287 (21.3)66/297 (22.1)1.05 (0.70 to 1.58)0.83
 HI total139 (23.8)67/287 (23.3)72/297 (24.2)1.05 (0.71 to 1.56)0.79
PH-134 (5.8)20/287 (7.0)14/297 (4.7)1.62 (0.79 to 3.31)0.19
PH-250 (8.6)31/287 (10.8)19/297 (6.4)1.85 (1.01 to 3.40)0.048
 PH total84 (14.4)51/287 (17.8)33/297 (11.1)1.75 (1.08 to 2.85)0.024
 Extra-parenchymal hemorrhage24 (4.1)11/287 (3.8)13/297 (4.4)0.96 (0.42 to 2.20)0.92
No hemorrhage337 (57.0)158 (55.1)179 0.3)1
  • *ICH Heidelberg Bleeding Classification subtype information was lost in 7 patients, 5 in intravenous alteplase and EVT group and 2 in EVT-only group.

  • aICH, asymptomatic intracranial hemorrhage; CI, confidence interval; EVT, endovascular thrombectomy; HI, hemorrhagic infarction; ICH, intracranial hemorrhage; OR, odds ratio; PH, parenchymal hematoma; sICH, symptomatic intracranial hemorrhage.